How is airflow obstruction diagnosed?
Spirometry showing reduced FEV1 and reduced FEV1/FVC ratio.
What spirometry pattern indicates obstruction?
Low FEV1 with low FEV1/FVC ratio.
Why is spirometry essential?
Symptoms alone cannot distinguish asthma, COPD, or bronchiectasis.
What happens to airway cross-sectional area peripherally?
It increases markedly.
Why does narrowing of a large airway cause early symptoms?
Large airways contribute significantly to resistance.
Why can small airway disease be asymptomatic initially?
Large total cross-sectional area masks early obstruction.
Relationship between resistance and airway radius?
Resistance is inversely proportional to radius (Poiseuille’s law).
Three common obstructive airway diseases?
Asthma, COPD, bronchiectasis.
Definition of asthma?
A heterogeneous disease with chronic airway inflammation and variable expiratory airflow limitation.
Key symptom pattern in asthma?
Symptoms vary over time and in intensity.
Acute changes in asthma?
Chronic changes in asthma?
How is reversibility tested?
Pre- and post-bronchodilator spirometry (400 mcg salbutamol).
Positive reversibility criteria?
≥200 mL and ≥12% increase in FEV1.
Greater confidence threshold?
≥400 mL and ≥15% increase.
Is PEFR effort dependent?
Yes.
How long should PEFR be monitored?
2–4 weeks (twice daily in adults).
Significant variability in PEFR?
> 10% (GINA) to >20% (NICE).
What does bronchial challenge test detect?
Bronchial hyperresponsiveness.
Mannitol challenge mechanism?
Triggers inflammatory mediator release → bronchoconstriction.
Normal FeNO level?
<25 ppb.
High FeNO level?
> 50 ppb.
NICE threshold supporting asthma diagnosis?
> 40 ppb.
What does high FeNO predict?
Good response to inhaled corticosteroids.